Merit Financial Group, LLC Genmab A/S Transaction History
Merit Financial Group, LLC
- $9.62 Billion
- Q3 2025
A detailed history of Merit Financial Group, LLC transactions in Genmab A/S stock. As of the latest transaction made, Merit Financial Group, LLC holds 6,526 shares of GMAB stock, worth $196,628. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,526Holding current value
$196,628% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GMAB
# of Institutions
248Shares Held
65.2MCall Options Held
32.5KPut Options Held
55K-
Alliancebernstein L.P. New York, NY10.7MShares$321 Million0.08% of portfolio
-
Orbis Allan Gray LTD Hamilton, D07.92MShares$239 Million1.07% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$153 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.57MShares$108 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA3.45MShares$104 Million0.05% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $19.8B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...